NCT04623879View on ClinicalTrials.gov

Real Life Evaluation of the Multi-organ Effects of Lumacaftor/Ivacaftor on F508del Homozygous Cystic Fibrosis Patients.

CompletedOBSERVATIONAL

Enrollment

13

Participants

Timeline

Start Date

December 29, 2016

Primary Completion Date

July 30, 2019

Study Completion Date

February 26, 2020

Conditions

Cystic Fibrosis

Interventions

DRUG

Lumacaftor, Ivacaftor Drug Combination

Sponsors

Lead Sponsor

Carmel Medical Center

All Listed Sponsors

lead

Carmel Medical Center

OTHER

NCT04623879 - Real Life Evaluation of the Multi-organ Effects of Lumacaftor/Ivacaftor on F508del Homozygous Cystic Fibrosis Patients. | Biotech Hunter | Biotech Hunter